MRC1 and neoplasm: Thus, in silico analysis of tumor patient data further corroborates the characteristic phenotype of cross-presenting CD206+ macrophages and functional outcomes of successful cross-presentation resulting in enhanced CD8+ T cell response, and it identifies CD206+ TAM as one of the major cross-presenting subsets found in tumor-infiltrating myeloid cells.